Heidi Anne Duerr, MPH

Take this quiz to see if you are leveraging the latest research in acne treatment.

Jane Mast, PhD, DMSc, MPAS, PA-C, shares her thoughts on the award, being a Derm PA, and dermatology.

Post-hoc analysis demonstrated secukinumab's efficacy in addressing both HS and HS-related psychiatric symptoms.

Dermatology physician associates via DPAF conduct skin checks at the Sun Bus during the Fall Conference.

SDPA President Amber Blair, PA-C, discusses new member opportunities and recognizes PA leaders.

Case studies demonstrate success with radiofrequency microneedling for hypertrophic scars in Fitzpatrick IV through VI.

Poster compared quality of life improvement for dupilumab vs lebrikizumab in atopic dermatitis.

Rick Guidotti, fashion photographer turned patient advocate, discusses reframing beauty through his nonprofit Positive Exposure.

At the SPDA conference, Meghan Heberton, MD, told attendees about the importance of oncodermatology in patient care.

SDPA President Laura Bush DMSc, PA-C, DFAAPA, shares exciting news about the name change as the Summer Conference begins to wind down.

Jennifer Hsiao, MD, shares insights on emerging therapies and comprehensive care strategies at the 2024 SDPA Annual Summer Dermatology Conference.

Luke Maxfield, DO, discusses the importance of understanding social media trends and engaging patients in dialogues.

Laura Bush, DMSc, PA-C, DFAAPA, talks to Renata Block, MMS, PA-C, about her SDPA presidency, the future, and the importance of a positive outlook.

Poster presented at the SDPA conference reported Effisayil 2 data indicating spesolimab improved Dermatology Life Quality Index scores in patients with generalized pustular psoriasis.

The JAK inhibitors have demonstrated efficacy, yet some clinicians are still wary of prescribing them. Amy Spizuoco, DO, FAOCD, shares tips to help clinicians improve their comfort in using them.

What are some of the opportunities and challenges facing PAs today? Renata Block, MMS, PA-C, shares insights and reflections on the field.

The results indicated improvement in PASI and sPGA scores as well as improvement in quality of life indicators in adults with moderate to severe psoriasis.

Researchers found dupilumab improved itch and skin lesions regardless of atopic disease status in patients with PN.

Robin Siperstein, MD, FAAD, shares practical tips in cosmetic dermatology at the 2024 SDPA Annual Summer Dermatology Meeting.

Session at the 2024 SDPA Annual Summer Dermatology Conference helps clinicians reframe beauty and empower patients.

From posters to sessions, this year's SDPA Summer Dermatology Conference was designed to provide clinicians with insights from leading experts.

With so many sessions and posters, there is a plethora of topics offered at this year's SDPA Summer Conference.

A poster from the 2024 American Psychiatric Association Annual Meeting delved into the relationship between MDD and various dermatologic conditions.

Paller shares early findings from the award winning poster on PEDISTAD trial and its clinical implication for children with atopic dermatitis.

Henry Lim, MD, shares insights on JAK inhibitor safety and the poster presented at the AAD Annual Meeting

"It's an exciting time" in dermatology, said Lee, who reflects on late-breaker data and other research presented at the 2024 AAD Annual Meeting.

Kim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.

The poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.

Jason S. Reichenberg, MD, MBA, FAAD, shares tips for improving interactions and communications at the 2024 AAD Annual Meeting.

How can you improve excision care for your patients with hidradenitis suppurativa? Ashley Nicole Elsensohn, MD, MPH, FAAD, shared clinical pearls at the AAD Annual Meeting.